Cargando…
Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging
BACKGROUND: Diabetes is a major risk factor for cardiovascular disease. In particular, type 1 diabetes compromises the cardiac function of individuals at a relatively early age due to the protracted course of abnormal glucose homeostasis. The functional abnormalities of diabetic myocardium have been...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1450259/ https://www.ncbi.nlm.nih.gov/pubmed/16595006 http://dx.doi.org/10.1186/1475-2840-5-7 |
_version_ | 1782127381810511872 |
---|---|
author | Loganathan, Rajprasad Bilgen, Mehmet Al-Hafez, Baraa Alenezy, Mohammed D Smirnova, Irina V |
author_facet | Loganathan, Rajprasad Bilgen, Mehmet Al-Hafez, Baraa Alenezy, Mohammed D Smirnova, Irina V |
author_sort | Loganathan, Rajprasad |
collection | PubMed |
description | BACKGROUND: Diabetes is a major risk factor for cardiovascular disease. In particular, type 1 diabetes compromises the cardiac function of individuals at a relatively early age due to the protracted course of abnormal glucose homeostasis. The functional abnormalities of diabetic myocardium have been attributed to the pathological changes of diabetic cardiomyopathy. METHODS: In this study, we used high field magnetic resonance imaging (MRI) to evaluate the left ventricular functional characteristics of streptozotocin treated diabetic Sprague-Dawley rats (8 weeks disease duration) in comparison with age/sex matched controls. RESULTS: Our analyses of EKG gated cardiac MRI scans of the left ventricle showed a 28% decrease in the end-diastolic volume and 10% increase in the end-systolic volume of diabetic hearts compared to controls. Mean stroke volume and ejection fraction in diabetic rats were decreased (48% and 28%, respectively) compared to controls. Further, dV/dt changes were suggestive of phase sensitive differences in left ventricular kinetics across the cardiac cycle between diabetic and control rats. CONCLUSION: Thus, the MRI analyses of diabetic left ventricle suggest impairment of diastolic and systolic hemodynamics in this rat model of diabetic cardiomyopathy. Our studies also show that in vivo MRI could be used in the evaluation of cardiac dysfunction in this rat model of type 1 diabetes. |
format | Text |
id | pubmed-1450259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-14502592006-04-29 Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging Loganathan, Rajprasad Bilgen, Mehmet Al-Hafez, Baraa Alenezy, Mohammed D Smirnova, Irina V Cardiovasc Diabetol Original Investigation BACKGROUND: Diabetes is a major risk factor for cardiovascular disease. In particular, type 1 diabetes compromises the cardiac function of individuals at a relatively early age due to the protracted course of abnormal glucose homeostasis. The functional abnormalities of diabetic myocardium have been attributed to the pathological changes of diabetic cardiomyopathy. METHODS: In this study, we used high field magnetic resonance imaging (MRI) to evaluate the left ventricular functional characteristics of streptozotocin treated diabetic Sprague-Dawley rats (8 weeks disease duration) in comparison with age/sex matched controls. RESULTS: Our analyses of EKG gated cardiac MRI scans of the left ventricle showed a 28% decrease in the end-diastolic volume and 10% increase in the end-systolic volume of diabetic hearts compared to controls. Mean stroke volume and ejection fraction in diabetic rats were decreased (48% and 28%, respectively) compared to controls. Further, dV/dt changes were suggestive of phase sensitive differences in left ventricular kinetics across the cardiac cycle between diabetic and control rats. CONCLUSION: Thus, the MRI analyses of diabetic left ventricle suggest impairment of diastolic and systolic hemodynamics in this rat model of diabetic cardiomyopathy. Our studies also show that in vivo MRI could be used in the evaluation of cardiac dysfunction in this rat model of type 1 diabetes. BioMed Central 2006-04-04 /pmc/articles/PMC1450259/ /pubmed/16595006 http://dx.doi.org/10.1186/1475-2840-5-7 Text en Copyright © 2006 Loganathan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Investigation Loganathan, Rajprasad Bilgen, Mehmet Al-Hafez, Baraa Alenezy, Mohammed D Smirnova, Irina V Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging |
title | Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging |
title_full | Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging |
title_fullStr | Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging |
title_full_unstemmed | Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging |
title_short | Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging |
title_sort | cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1450259/ https://www.ncbi.nlm.nih.gov/pubmed/16595006 http://dx.doi.org/10.1186/1475-2840-5-7 |
work_keys_str_mv | AT loganathanrajprasad cardiacdysfunctioninthediabeticratquantitativeevaluationusinghighresolutionmagneticresonanceimaging AT bilgenmehmet cardiacdysfunctioninthediabeticratquantitativeevaluationusinghighresolutionmagneticresonanceimaging AT alhafezbaraa cardiacdysfunctioninthediabeticratquantitativeevaluationusinghighresolutionmagneticresonanceimaging AT alenezymohammedd cardiacdysfunctioninthediabeticratquantitativeevaluationusinghighresolutionmagneticresonanceimaging AT smirnovairinav cardiacdysfunctioninthediabeticratquantitativeevaluationusinghighresolutionmagneticresonanceimaging |